Clinical trial
A Prospective Study Evaluating the Incidence of Nephrogenic Systemic Fibrosis in Patients With Stages 4 to 5 Chronic Kidney Disease Without Exposure to Gadolinium Based Contrast Agents Within the Past 10 Years
NCT00773409 is registered in ClinicalTrials.gov with Bracco Diagnostics, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Study Evaluating the Incidence of Nephrogenic Systemic Fibrosis in Patients With Stages 4 to 5 Chronic Kidney Disease Without Exposure to Gadolinium Based Contrast Agents Within the Past 10 Years
- Lead sponsor
- Bracco Diagnostics, Inc
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2008
- Completion date
- July 31, 2012
- Enrollment
- 405 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.